8-K 1 v125723_8k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): August 31, 2008
 
 
SINOBIOMED INC.
(Exact name of registrant as specified in its charter)
 
 
Commission File Number 333-128399
 
Delaware
 
20-1945139
(State or other jurisdiction
of incorporation)
 
(I.R.S. Employer
Identification No.)

Lane 4705, No. 58, North Yang Gao Rd.
Pudong New Area Shanghai, China 201206
(Address of principal executive offices, including Zip Code)
 
Registrant’s telephone number, including area code: 011-86-21-58546923

N/A
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
1
 
 
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Effective August 31, 2008, Mr. Asher Zwebner, CFO of Sinobiomed, Inc. (the “Company”), resigned from such position without having any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

Item 8.01. Other Events

Pursuant to Form 8-K, General Instructions F, registrant hereby incorporates by reference the press releases attached hereto as Exhibits 99.1, 99.2 and 99.3.

Item 9.01. Financial Statements and Exhibits
 
Exhibit No.
Description
   
99.1
Press release dated August 13, 2008
99.2
Press release dated August 20, 2008
99.3
Press release dated August 21, 2008

 
 
2
 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
SINOBIOMED INC.
     
 
By:
/s/ Ka Yu                              
 
Name:
Ka Yu
 
Title:
Director
 
Date: September 4, 2008
 
 
3